New aspects of 24(S)-hydroxycholesterol in modulating neuronal cell death

Free Radical Biology and Medicine

Volumn 87, Issue , 2015, Pages 366-372

  Noguchi, Noriko ^a   Urano, Yasuomi ^a   Takabe, Wakako ^a   Saito, Yoshiro ^a  

^a DOSHISHA UNIVERSITY   (Japan)

Author keywords

24(S) Hydroxycholesterol; Cell death; Cholesterolhomeostasis; CYP46A1; Freeradicals; Neurodegenerativedisease

Indexed keywords

24 HYDROXYCHOLESTEROL; AMYLOID PRECURSOR PROTEIN; CASPASE 8; CHOLESTEROL DERIVATIVE; LIVER X RECEPTOR; OXYSTEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; ORPHAN NUCLEAR RECEPTOR;

DOWN REGULATION; HUMAN; NECROPTOSIS; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; ANIMAL; AUTOPHAGY; BRAIN; CELL DEATH; DEGENERATIVE DISEASE; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY;

AMYLOID BETA-PEPTIDES; ANIMALS; AUTOPHAGY; BRAIN; CELL DEATH; HUMANS; HYDROXYCHOLESTEROLS; NEURODEGENERATIVE DISEASES; NEURONS; ORPHAN NUCLEAR RECEPTORS; OXIDATIVE STRESS;

EID: 84944324351     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.036     Document Type: Review

References (94)

1. I. Björkhem, and S. Meaney Brain cholesterol: long secret life behind a barrier Arterioscler. Thromb. Vasc. Biol. 24 2004 806 815
2. H. Jurevics, and P. Morell Cholesterol for synthesis of myelin is made locally, not imported into brain J. Neurochem. 64 1995 895 901
3. J.M. Dietschy, and S.D. Turley Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J. Lipid Res. 45 2004 1375 1397
4. F.W. Pfrieger, and N. Ungerer Cholesterol metabolism in neurons and astrocytes Prog. Lipid Res. 50 2011 357 371
5. A.A. Saeed, G. Genové, T. Li, D. Lütjohann, M. Olin, N. Mast, I.A. Pikuleva, P. Crick, Y. Wang, W. Griffiths, C. Betsholtz, and I. Björkhem Effects of a disrupted blood-brain barrier on cholesterol homeostasis in the brain J. Biol. Chem. 289 2014 23712 23722
6. I. Björkhem, A. Cedazo-Minguez, V. Leoni, and S. Meaney Oxysterols and neurodegenerative diseases Mol. Aspects Med. 30 2009 171 179
7. D.W. Russell, R.W. Halford, D.M. Ramirez, R. Shah, and T. Kotti Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain Annu. Rev. Biochem. 78 2009 1017 1040
8. I. Björkhem, D. Lütjohann, O. Breuer, A. Sakinis, and A. Wennmalm Importance of a novel oxidative mechanism for elimination of brain cholesterol J. Biol. Chem. 48 1997 30178 30184
9. I. Björkhem, U. Diczfalusy, and D. Lütjohann Removal of cholesterol from extrahepatic sources by oxidative mechanisms Curr. Opin. Lipidol. 10 1999 161 165
10. S. Ohtsuki, S. Ito, A. Matsuda, S. Hori, T. Abe, and T. Terasaki Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier J. Neurochem. 103 2007 1430 1438
11. E.G. Lund, C. Xie, T. Kotti, S.D. Turley, J.M. Dietschy, and D.W. Russell Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover J. Biol. Chem. 278 2003 22980 22988
12. D. Lütjohann, O. Breuer, G. Ahlborg, I. Nennesmo, A. Sidén, U. Diczfalusy, and I. Björkhem Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation Proc. Natl. Acad. Sci. USA 93 1996 9799 9804
13. A. Radhakrishnan, Y. Ikeda, H.J. Kwon, M.S. Brown, and J.L. Goldstein Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig Proc. Natl. Acad. Sci. USA 104 2007 6511 6518
14. S.B. Joseph, E. McKilligin, L. Pei, M.A. Watson, A.R. Collins, B.A. Laffitte, M. Chen, G. Noh, J. Goodman, G.N. Hagger, J. Tran, T.K. Tippin, X. Wang, A.J. Lusis, W.A. Hsueh, R.E. Law, J.L. Collins, T.M. Willson, and P. Tontonoz Synthetic LXR ligand inhibits the development of atherosclerosis in mice Proc. Nat. Acad. Sci. USA 99 2002 7604 7609
15. F. Gosselet, J. Saint-Pol, and L. Fenart Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease Biochem. Biophys. Res. Commun. 446 2014 687 691
16. D.E. Schmechel, A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Pericak-Vance, D. Goldgaber, and A.D. Roses Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease Proc. Natl. Acad. Sci. USA 90 1993 9649 9653
17. H. Kölsch, D. Lütjohann, M. Ludwig, A. Schulte, U. Ptok, F. Jessen, K. von Bergmann, M.L. Rao, W. Maier, and R. Heun Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease Mol. Psychiatry 7 2002 899 902
18. M. Heverin, N. Bogdanovic, D. Lütjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad, and I. Björkhem Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease J. Lipid Res. 45 2004 186 193
19. D. Lütjohann, A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli, R.D. Oehring, U. Schlegel, F. Jessen, M.L. Rao, K. von Bergmann, and R. Heun Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients J. Lipid Res. 41 2000 195 198
20. G. Zuliani, M.P. Donnorso, C. Bosi, A. Passaro, N.E. Dalla, A. Zurlo, F. Bonetti, A.F. Mozzi, and C. Cortese Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study BMC Neurol. 11 2011 121
21. M. Shafaati, A. Solomon, M. Kivipelto, I. Björkhem, and V. Leoni Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxychholesterol in patients with cognitive disorders Neurosci. Lett. 425 2007 78 82
22. L. Bretillon, A. Sidén, L.O. Wahlund, D. Lütjohann, L. Minthon, M. Crisby, J. Hillert, C.G. Groth, U. Diczfalusy, and I. Björkhem Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases Neurosci. Lett. 293 2000 87 90
23. H. Kölsch, R. Heun, A. Kerksiek, K.V. Bergmann, W. Maier, and D. Lütjohann Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients Neurosci. Lett. 368 2004 303 308
24. I. Björkhem, A. Lövgren-Sandblom, V. Leoni, S. Meaney, L. Brodin, L. Salveson, and et al. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease Neurosci. Lett. 555 2013 102 105
25. C.Y. Lee, R.C. Seet, S.H. Huang, L.H. Long, and B. Halliwell Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke, and Parkinson's disease patients: cautions in the use of biomarkers of oxidative stress Antioxid. Redox Signaling 11 2009 407 420
26. V. Leoni, J.D. Long, J.A. Mills, S. Di Donato, and J.S. Paulsen Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression Neurobiol. Dis. 55 2013 37 43
27. V. Leoni, and C. Caccia Oxysterols as biomarkers in neurodegenerative diseases Chem. Phys. Lipids 164 2011 515 524
28. I. Björkhem Crossing the barrier, oxysterols as cholesterol transporters and metabolic modulators in the brain J. Intern. Med. 260 2006 493 508
29. T.M. Hughes, C. Rosano, R.W. Evans, and L.H. Kuller Brain cholesterol metabolism, oxysterols, and dementia J. Alzheimers Dis. 33 2013 891 911
30. B. Sottero, P. Gamba, S. Gargiulo, S. Leonarduzzi, and G. Poli Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry Curr. Med. Chem. 16 2009 685 705
31. L. Iuliano Pathways of cholesterol oxidation via non-enzymatic mechanisms Chem. Phys. Lipids 164 2011 457 458
32. G. Poli, F. Biasi, and G. Leonarduzzi Oxysterols in the pathogenesis of major chronic diseases Redox Biol 1 2013 125 130
33. E. Niki Lipid peroxidation: physiological levels and dual biological effects Free Radic. Biol. Med. 47 2009 469 484
34. T.J. Nelson, and D.L. Alkon Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide J. Biol. Chem. 280 2005 7377 7387
35. A. Vejux, L. Malvitte, and G. Lizard Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis Braz. J. Med. Biol. Res. 41 2008 545 556
36. Y. Saito, and N. Noguchi 7-Hydroxycholestrol as a possible biomarker of cellular lipid peroxidation: difference between cellular and plasma lipid peroxidation Biochem. Biophys. Res. Commun. 446 2014 741 744
37. T. Mitić, R. Andrew, B.R. Walker, and P.W. Hadoke 11β-Hydroxysteroid dehydrogenase type 1 contributes to the regulation of 7-oxysterol levels in the arterial wall through the inter-conversion of 7-ketocholesterol and 7β-hydroxycholesterol Biochimie 95 2013 548 555
38. J. Poirier, A. Baccichet, D. Dea, and S. Gauthier Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats Neuroscience 55 1993 81 90
39. D.M. Ramirez, S. Andersson, and D.W. Russell Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain J. Comp. Neurol. 507 2008 1676 1693
40. N. Bogdanovic, L. Bretillon, E.G. Lund, U. Diczfalusy, L. Lannfelt, B. Winblad, D.W. Russell, and I. Björkhem On the turnover of brain cholesterol in patients with Alzheimer's disease: abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells Neurosci. Lett. 314 2001 45 48
41. J., 3rd Brown, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J.M. Lee, D. Yager, J. Crowley, K. Sambamurti, M.M. Rahman, A.B. Reiss, C.B. Eckman, and B. Wolozin Differential expression of cholesterol hydroxylases in Alzheimer's disease J. Biol. Chem. 279 2004 34674 34681
42. Y. Ohyama, S. Meaney, M. Heverin, L. Ekström, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, E. Feinstein, and I. Björkhem Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1) J. Biol. Chem. 281 2006 3810 3820
43. C. Patte-Mensah, and A.G. Mensah-Nyagan Peripheral neuropathy and neurosteroid formation in the central nervous system Brain Res. Rev. 57 2008 454 459
44. S.R. Doodipala Neurosteroids: endogenous role in the human brain and therapeutic potentials Prog. Brain Res. 186 2010 113 137
45. J.L. Do Rego, J.Y. Seong, D. Burel, J. Leprince, V. Luu-The, K. Tsutsui, M.C. Tonon, G. Pelletier, and H. Vaudry Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides Front. Neuroendocrinol. 30 2009 259 301
46. I.H. Zwain, and S.S. Yen Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain Endocrinology 140 1999 3843 3852
47. A receptors Trends Neurosci. 33 2010 299 306
48. M.Y. Sun, A.J. Linsenbardt, C.M. Emnett, L.N. Eisenman, Y. Izumi, C.F. Zorumski, and S. Mennerick 24(S)-hydroxycholesterol as a modulator of neuronal signaling and survival Neuroscientist 2015 1 13
49. E. Hudry, D. Van Dam, W. Kulik, P.P. De Deyn, F.S. Stet, O. Ahouansou, A. Benraiss, A. Delacourte, P. Bougnères, P. Aubourg, and N. Cartier Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease Mol. Ther. 18 2010 44 53
50. R.W. Halford, and D.W. Russell Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan Proc. Natl. Acad. Sci. USA 106 2009 3502 3506
51. N. Mast, C. Charvet, I.A. Pikuleva, and C.D. Stout Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain J. Biol. Chem. 285 2010 31783 31795
52. M. Shafaati, N. Mast, O. Beck, R. Nayef, G.Y. Heo, L. Björkhem-Bergman, D. Lütjohann, I. Björkhem, and I.A. Pikuleva The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo J. Lipid Res. 51 2010 318 323
53. C. Fourgeux, L. Martine, N. Acar, A.M. Bron, C.P. Creuzot-Garcher, and L. Bretillon In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina Biochem. Biophys. Res. Commun. 446 2014 775 781
54. Y. Huang, W. Li, and A.N. Kong Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal Cell Biosci 2 2012 40
55. Z.H. Chen, Y. Yoshida, Y. Saito, A. Sekine, N. Noguchi, and E. Niki Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta(12,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms J. Biol. Chem. 281 2006 14440 14445
56. Y. Saito, K. Nishio, Y. Numakawa, Y. Ogawa, Y. Yoshida, N. Noguchi, and E. Niki Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione J. Neurochem. 102 2007 1625 1634
57. M.L. Rao, D. Lütjohann, M. Ludwig, and H. Kölsch Induction of apoptosis and necrosis in human neuroblastoma cells by cholesterol oxides Ann. N.Y. Acad. Sci. 893 1999 379 381
58. D.E. Kim, Y.C. Youn, Y.K. Kim, K.M. Hong, and C.S. Lee Glycyrrhizin prevents 7-ketocholesterol toxicity against differentiated PC12 cells by suppressing mitochondrial membrane permeability change Neurochem. Res. 34 2009 1433 1442
59. E.R. Jang, and C.S. Lee 7-Ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-κB and Akt pathways Neurochem. Int. 58 2011 52 59
60. A. Okabe, Y. Urano, S. Itoh, N. Suda, R. Kotani, Y. Nishimura, Y. Saito, and N. Noguchi Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death Redox Biol. 2 2013 28 35
61. P.J. Willy, K. Umesono, E.S. Ong, R.M. Evans, R.A. Heyman, and D.J.L.X.R. Mangelsdorf a nuclear receptor that defines a distinct retinoid response pathway Genes Dev. 9 1995 1033 1045
62. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
63. D.T. Loo, A. Copani, C.J. Pike, E.R. Whittemore, A.J. Walencewicz, and C.W. Cotman Apoptosis is induced by beta-amyloid in cultured central nervous system neurons Proc. Natl. Acad. Sci. USA 90 1993 7951 7955
64. S. Estus, H.M. Tucker, C. van Rooyen, S. Wright, E.F. Brigham, M. Wogulis, and R.E. Rydel Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction J. Neurosci. 17 1997 7736 7745
65. J.R. Prasanthi, A. Huls, S. Thomasson, A. Thompson, E. Schommer, and O. Ghribi Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells Mol. Neurodegener 4 2009 1
66. D. Cai, J.Y. Leem, J.P. Greenfield, P. Wang, B.S. Kim, R. Wang, K.O. Lopes, S.H. Kim, H. Zheng, P. Greengard, S.S. Sisodia, G. Thinakaran, and H. Xu Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein J. Biol. Chem. 278 2003 3446 3454
67. J. Kim, S. Hamamoto, M. Ravazzola, L. Orci, and R. Schekman Uncoupled packaging of amyloid precursor protein and presenilin 1 into coat protein complex II vesicles J. Biol. Chem. 280 2005 7758 7768
68. Y. Urano, I. Hayashi, N. Isoo, P.C. Reid, Y. Shibasaki, N. Noguchi, T. Tomita, T. Iwatsubo, T. Hamakubo, and T. Kodama Association of active gamma-secretase complex with lipid rafts J. Lipid Res. 46 2005 904 912
69. Y. Urano, S. Ochiai, and N. Noguchi Suppression of amyloid-β production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking FASEB J 27 2013 4305 4315
70. V. Cavallucci, M. D'Amelio, and F. Cecconi Aβ toxicity in Alzheimer's disease Mol. Neurobiol. 45 2012 366 378
71. E. Hubin, N.A. van Nuland, K. Broersen, and K. Pauwels Transient dynamics of Aβ contribute to toxicity in Alzheimer's disease Cell Mol. Life Sci. 71 2014 3507 3521
72. Q. Wang, X. Yu, L. Li, and J. Zheng Inhibition of amyloid-β aggregation in Alzheimer's disease. Curr. Pharm. Des 20 2014 1223 1243
73. P. Gamba, M. Guglielmotto, G. Testa, D. Monteleone, C. Zerbinati, S. Gargiulo, F. Biasi, L. Iuliano, G. Giaccone, A. Mauro, G. Poli, E. Tamagno, and G. Leonarduzzi Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine Aging Cell 13 2014 561 572
74. J. Popp, P. Lewczuk, H. Kölsch, S. Meichsner, W. Maier, J. Kornhuber, F. Jessen, and D. Lütjohann Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease J. Neurochem. 123 2012 310 316
75. H. Fukumoto, A. Deng, M.C. Irizarry, M.L. Fitzgerald, and G.W. Rebeck Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels J. Biol. Chem. 277 2002 48508 48513
76. P. Ferrera, O. Mercado-Gómez, M. Silva-Aguilar, M. Valverde, and C. Arias Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress Neurochem. Res. 33 2008 1509 1517
77. Z. Kristofiková, V. Kopecký Jr, K. Hofbauerová, P. Hovorková, and D. Rípová Complex of amyloid beta peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers Neurochem. Res. 33 2008 412 421
78. P. Gamba, G. Leonarduzzi, E. Tamagno, M. Guglielmotto, G. Testa, B. Sottero, S. Gargiulo, F. Biasi, A. Mauro, J. Viña, and G. Poli Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime Aging Cell 10 2011 403 417
79. Z. Kristofiková, Z. Kríž, D. Rípová, and J. Kocá Interactions of amyloid β peptide 1-40 and cerebrosterol. Neurochem. Res. 37 2012 604 613
80. H. Kölsch, D. Lütjohann, A. Tulke, I. Björkhem, and M.L. Rao The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells Brain Res. 818 1999 171 175
81. H. Kölsch, M. Ludwig, D. Lütjohann, and M.L. Rao Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β. J. Neural Transmission 108 2001 475 488
82. N. Noguchi, Y. Saito, and Y. Urano Diverse functions of 24(S)-hydroxycholesterol in the brain: a special issue on oxysterols Biochem. Biophys. Res. Commun. 446 2014 692 696
83. K. Yamanaka, Y. Saito, T. Yamamori, Y. Urano, and N. Noguchi 24(S)-Hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis J. Biol. Chem. 286 2011 24666 24673
84. K. Yamanaka, Y. Saito, J. Sakiyama, Y. Ohuchi, F. Oseto, and N. Noguchi A novel fluorescent probe with high sensitivity and selective detection of lipid hydroperoxides in cells RSC Adv 2 2012 7894 7900
85. M. Jiang, K. Zhu, J. Grenet, and J.M. Lahti Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells Biochim. Biophys. Acta 1783 2008 1055 1067
86. L. Sun, H. Wang, Z. Wang, S. He, S. Chen, D. Liao, L. Wang, J. Yan, W. Liu, X. Lei, and X. Wang Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase Cell 148 2012 213 227
87. H. Wang, L. Sun, L. Su, J. Rizo, L. Liu, L.F. Wang, F.S. Wang, and X. Wang Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3 Mol. Cell 54 2014 133 146
88. A. Degterev, J. Hitomi, M. Germscheid, I.L. Ch'en, O. Korkina, X. Teng, D. Abbott, G.D. Cuny, C. Yuan, G. Wagner, S.M. Hedrick, S.A. Gerber, A. Lugovskoy, and J. Yuan Identification of RIP1 kinase as a specific cellular target of necrostatins Nat. Chem. Biol. 4 2008 313 321
89. D.K. Vo, Y. Urano, W. Takabe, Y. Saito, and N. Noguchi 24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8 Steroids 99 2015 230 237
90. K. Yamanaka, Y. Urano, W. Takabe, Y. Saito, and N. Noguchi Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA:cholesterol acyltransferase 1 Cell Death Dis. 5 2014 e990
91. T.Y. Chang, B.L. Li, C.C. Chang, Y. Urano, and A. Acyl-coenzyme cholesterol acyltransferases Am. J Physiol. Endocrinol. Metab. 297 2009 E1 9
92. V.L. Marca, M.S. Spagnuolo, L. Cigliano, D. Marasco, and P. Abrescia The enzyme lecithin-cholesterol acyltransferase esterifies cerebrosterol and limits the toxic effect of this oxysterol on SH-SY5Y cells J. Neurochem. 130 2014 97 108
93. M.X. He, and Y.W. He A role for c-FLIP(L) in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes Cell Death Differ. 20 2013 188 197
94. M. Feoktistova, P. Geserick, B. Kellert, D.P. Dimitrova, C. Langlais, M. Hupe, K. Cain, M. MacFarlane, G. Häcker, and M. Leverkus cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms Mol. Cell 43 2011 449 463